FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

H Hashizume

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Disorders

Physiology

Energy Metabolism

Co-author Network

Publications

TOP 3
K Maruyama; Akiyoshi Hara; H Hashizume; Fumitaka Ushikubi; Y Abiko
Ranolazine attenuates palmitoyl-L-carnitine-induced mechanical and metabolic derangement in the isolated, perfused rat heart.
Akiyoshi Hara; T Suzuki; H Hashizume; N Shishido; M Nakamura; F Ushikubi; Y Abiko
Effects of CP-060S, a novel Ca(2+) channel blocker, on oxidative stress in cultured cardiac myocytes.
H Hashizume; Y Abiko
[Cardiac cell injury induced by lysophosphatidylcholine].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of H Hashizume (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: K Maruyama; Akiyoshi Hara; H Hashizume; Fumitaka Ushikubi; Y Abiko
Ranolazine attenuates palmitoyl-L-carnitine-induced mechanical and metabolic derangement in the isolated, perfused rat heart.
The Journal of pharmacy and pharmacology 2000;52(6):709-15.
1999: Akiyoshi Hara; T Suzuki; H Hashizume; N Shishido; M Nakamura; F Ushikubi; Y Abiko
Effects of CP-060S, a novel Ca(2+) channel blocker, on oxidative stress in cultured cardiac myocytes.
European journal of pharmacology 1999;385(1):81-8.
1999: H Hashizume; Y Abiko
[Cardiac cell injury induced by lysophosphatidylcholine].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1999;114(5):287-93.
1999: Akiyoshi Hara; J Arakawa; Chun-Yang Xiao; H Hashizume; Fumitaka Ushikubi; Y Abiko
Inhibition of Na+ channel or Na+/H+ exchanger attenuates the hydrogen peroxide-induced derangements in isolated perfused rat heart.
The Journal of pharmacy and pharmacology 1999;51(9):1049-58.
1999: Chun-Yang Xiao; Akiyoshi Hara; H Hashizume; K Tanaka; Y Abiko
Both D-cis- and L-cis-diltiazem attenuate hydrogen peroxide-induced derangements in rat hearts.
European journal of pharmacology 1999;374(3):387-98.
1999: Hong Ma; H Hashizume; Akiyoshi Hara; K Yazawa; Y Abiko
Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Japanese journal of pharmacology 1999;79(1):17-24.
1998: M Chen; Chun-Yang Xiao; H Hashizume; Y Abiko
Phospholipase A2 is not responsible for lysophosphatidylcholine-induced damage in cardiomyocytes.
The American journal of physiology 1998;275(5 Pt 2):H1782-7.
1998: H Matsumura; Akiyoshi Hara; H Hashizume; K Maruyama; Y Abiko
Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: comparison with dichloroacetate.
Japanese journal of pharmacology 1998;77(1):31-9.
1998: H Hashizume; M Chen; Hong Ma; Akiyoshi Hara; K Yazawa; M Akahira; Chun-Yang Xiao; Y Abiko
A new approach to the development of anti-ischemic drugs: protective drugs against cell injury induced by lysophosphatidylcholine.
Life sciences 1998;62(17-18):1695-9.
1998: M Akahira; Akiyoshi Hara; H Hashizume; M Nakamura; Y Abiko
Protective effect of prazosin on the hydrogen peroxide-induced derangements in the isolated perfused rat heart.
Life sciences 1998;62(19):1755-66.
1997: Y Nasa; A N Hoque; K Ichihara; H Hashizume; Y Abiko
Protective effect of amiloride against reperfusion damage as evidenced by inhibition of accumulation of free fatty acids in working rat hearts.
Japanese circulation journal 1997;61(12):1021-9.
1997: Chun-Yang Xiao; M Chen; Akiyoshi Hara; H Hashizume; Y Abiko
Palmitoyl-L-carnitine modifies the myocardial levels of high-energy phosphates and free fatty acids.
Basic research in cardiology 1997;92(5):320-30.
1997: M Chen; Chun-Yang Xiao; H Hashizume; Y Abiko
Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
European journal of pharmacology 1997;333(2-3):261-8.
1997: Akiyoshi Hara; N Hayase; H Hashizume; Y Abiko
Protective effects of dilazep and its derivative K-7259 on the haemolysis induced by amphiphiles in rat erythrocytes.
The Journal of pharmacy and pharmacology 1997;49(8):806-11.
1997: Akiyoshi Hara; J Arakawa; H Hashizume; Y Abiko
Beneficial effects of dilazep on the palmitoyl-L-carnitine-induced derangements in isolated, perfused rat heart: comparison with tetrodotoxin.
Japanese journal of pharmacology 1997;74(2):147-53.
1997: A N Hoque; N Hoque; Akiyoshi Hara; H Hashizume; K Ichihara; Y Abiko
Cardioprotective effect of K-7259, a novel dilazep derivative, against ischemia-reperfusion damage in isolated, working rat hearts.
Japanese journal of pharmacology 1997;73(4):365-9.
1997: H Hashizume; A N Hoque; K Magishi; Akiyoshi Hara; Y Abiko
A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Japanese heart journal 1997;38(1):11-25.
1997: M Chen; H Hashizume; Chun-Yang Xiao; Akiyoshi Hara; Y Abiko
Lysophosphatidylcholine induces Ca2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes.
Life sciences 1997;60(3):PL57-62.
1996: Y Abiko; H Hashizume; Akiyoshi Hara
[A new approach to the understanding of the mechanism of ischemia/reperfusion damage in the heart and the effects of anti-ischemic drugs].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 1996;108(4):195-202.
1996: Akiyoshi Hara; H Hashizume; Y Abiko
Dilazep and its derivative, K-7259, attenuate mechanical derangement induced by palmitoyl-L-carnitine in the isolated, perfused rat heart.
The Journal of pharmacology and experimental therapeutics 1996;279(1):32-8.
1996: M Chen; H Hashizume; Y Abiko
Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.
British journal of pharmacology 1996;118(4):865-70.
1996: N Hoque; A N Hoque; H Hashizume; K Ichihara; Y Abiko
K-7259, a novel dilazep derivative, and d-propranolol attenuate H2O2-induced cell damage.
The Journal of pharmacology and experimental therapeutics 1996;277(1):207-11.
1995: A N Hoque; N Hoque; H Hashizume; Y Abiko
A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Japanese journal of pharmacology 1995;67(3):233-41.
1995: A N Hoque; N Hoque; H Hashizume; Y Abiko
A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart.
Japanese journal of pharmacology 1995;67(3):225-32.
1994: H Hashizume; K Akiyama; Y Abiko
Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes.
European journal of pharmacology 1994;271(1):1-8.
1993: Yoshihisa Nasa; H Hashizume; A N Hoque; Y Abiko
Protective effect of crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart.
Arzneimittel-Forschung 1993;43(9):945-9.
1988: I Miura; H Hashizume; Y Abiko
Propranolol inhibits accumulation of non-esterified fatty acids in the ischemic dog heart.
European journal of pharmacology 1988;152(3):281-8.
1988: H Hashizume; Y Abiko
Rapid changes in myofibrillar proteins after reperfusion of ischemic myocardium in dogs.
Basic research in cardiology 1988;83(3):250-7.